http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08283232-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eccd894c99fea2d1c0c8735872bb2309
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C317-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C317-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C315-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C317-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C317-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C317-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C279-18
filingDate 1995-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2e29e91c101d66b76a47e655ab6f4ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c5d9f3b0feae24a71c55b1e9e841b25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2730d9581be549b00e47ba36d2f252b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_744da513d5b372dec0d6ab9fdcea35cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bae82f7b06e5bd16044db86a6fb47520
publicationDate 1996-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H08283232-A
titleOfInvention Alkyl-5-methylsulfonylbenzoylguanidine derivative
abstract (57) [Summary] (Correction) [PROBLEMS] To provide a novel compound having useful properties, particularly a novel compound that can be used for producing a medicament. A benzoylguanidine derivative represented by the following formula (I) and a physiologically acceptable salt thereof: Wherein R 1 is methyl or ethyl, and R 2 Is H, or a linear or branched C 1 -C 6 - alkyl or alkenyl group, C 3 ~C 7 - A cycloalkyl group, a benzyl group or a phenyl group having 1, 2 or 3 methyl, methoxy, amino, F, Cl, Br or CF 3 as an unsubstituted or substituted group.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003532704-A
priorityDate 1994-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15521418
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10095
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227102583
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9950153
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234306559
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID233885344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76630

Total number of triples: 39.